{"id":"W2132546867","doi":"10.1038/ng.2529","title":"The genetic landscape of high-risk neuroblastoma","year":2013,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1219,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Human Genome Research Institute; National Institute on Minority Health and Health Disparities; Canadian Institutes of Health Research; National Institutes of Health","keywords":"ATRX; Biology; Neuroblastoma RAS viral oncogene homolog; PTPN11; Neuroblastoma; Germline mutation; Germline; Exome sequencing; CHEK2; Genetics; Somatic cell; Cancer research; Mutation; Exome; Gene; KRAS","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005299584076040456,"score_gpt":0.2492781974386105,"score_spread":0.2439786133625701,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}